CION Ameerpet
Theranostics explained
Theranostics — Treatment With Radioactive Medicine, Explained
Theranostics means a scan finds the target first, and then a matched radioactive medicine treats it from inside the body. The same targeting molecule does both jobs. It is used in selected cancers, and only when the scan is positive — which is exactly why the scan comes first.
Medically reviewed by Dr. Gangadhar Vajrala, Radiation Oncologist, MBBS · MD (Radiation Oncology) · MPH · Last reviewed August 2026
- Scan first, then treat — the targeting scan is the eligibility test; if your cancer cells do not carry the target, the paired treatment is not offered.
- Works from inside, not from a beam — the medicine travels in the bloodstream and can reach disease in several sites at once, unlike a beam aimed at one mapped area.
- Used in specific cancers — thyroid cancer, neuroendocrine tumours, some advanced prostate cancers, certain liver tumours and cancer that has spread to bone.
- Coordinated, not oversold — treatment is delivered at an NABH-accredited partner centre with a licensed nuclear medicine department; CION coordinates your plan, your team and your care.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The direct answer
What is theranostics cancer treatment?
Theranostics joins diagnosis and treatment into one system. A scan is done first, using a tiny amount of a radioactive tracer that seeks out a specific target on cancer cells. If the scan lights up, the same targeting molecule is given again — this time carrying a stronger radioactive particle. The treatment therefore lands exactly where the scan already found disease.
The word itself is a join of therapy and diagnostics. Clinicians often describe the idea in one line: see what you treat, treat what you see. That matters because the scan is not just a picture. It is the eligibility test. If your cancer cells do not carry the target, the paired treatment is not offered to you.
This is one of the fastest-moving areas in cancer care, and one of the least explained to Indian patients in plain language. Most families first hear the word from a doctor, a relative abroad, or a search result written for another country. This page sets out what it is, which cancers it applies to and how it is actually given, without overselling it.
The key difference
How does theranostics differ from external radiation?
External radiation aims a beam at a mapped area from a machine outside your body. Theranostics puts the radiation inside a medicine. That medicine travels in the bloodstream and attaches to cancer cells wherever they are. One treats a defined region very precisely. The other can reach disease sitting in several places at once.
Neither replaces the other, and neither is better in general. They answer different clinical problems, and many patients receive both at different points in their care. Here is how they actually differ.
| Factor | External beam radiation | Theranostics |
|---|---|---|
| How the radiation reaches the cancer | A beam aimed from a machine outside the body | A radioactive medicine carried through the bloodstream |
| What it can treat | One mapped area, or a few defined areas | Disease in several sites at once, if the cells carry the target |
| What decides suitability | Tumour location, size and nearby organs on a planning scan | Whether a targeting scan shows the cancer cells carry the target |
| How it is given | Short daily sittings on a treatment couch | An injection or drip into a vein, or a capsule or drink |
| Typical course | Often several sittings a week over some weeks | Usually a small number of cycles, several weeks apart |
| Radioactivity afterwards | None from standard external beam treatment | Present for a defined period, with written household precautions |
| Where it is delivered | Radiotherapy department at a partner centre | Licensed nuclear medicine department at a partner centre |
Did you know?
Theranostics is not a new idea. Radioactive iodine has been used to scan and then treat thyroid cancer since the 1940s, which makes thyroid cancer the original scan-and-treat pair. What changed recently is the number of targets that can be found and treated the same way — not the underlying principle.
Where it is used
Which cancers is theranostics used for?
Theranostics is not used for every cancer. It is used where cancer cells reliably carry a target that a radioactive medicine can lock onto. Today that mainly means thyroid cancer, neuroendocrine tumours, some advanced prostate cancers, certain liver tumours and cancer that has spread to bone. Your targeting scan decides, not the cancer name alone.
The original pair
Thyroid cancer
Radioactive iodine has been used for decades after thyroid surgery. The thyroid naturally takes up iodine, so a radioactive form of it concentrates in any remaining thyroid or thyroid-cancer tissue.
Receptor-targeted
Neuroendocrine tumours
These tumours often carry a receptor on their surface. A molecule that binds that receptor is used first for a scan, then paired with a treating isotope for patients whose scan is positive.
Advanced disease
Advanced prostate cancer
An agent that binds a protein carried on prostate cancer cells is used to scan, then to treat, in selected patients whose disease has progressed after standard treatment.
Delivered through an artery
Liver tumours
Tiny radioactive beads are placed into the artery feeding the tumour, so the dose is deposited in the tumour and far less reaches the rest of the liver.
Pain control
Cancer spread to bone
Bone-seeking radioactive agents settle in areas of active bone repair. They are used in selected patients to help control pain from bone metastases.
Always conditional
Everything depends on the scan
Even within these cancers, a negative targeting scan means the paired treatment is not offered. A positive scan is the entry condition, and it is checked before every course.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Talk to a Specialist About Theranostics
Bring your scan and pathology reports — our team explains, in plain language, whether a scan-and-treat approach is appropriate for you.
Step by step
How is theranostics actually given?
Most theranostic treatments are given as a slow injection or drip into a vein. Some thyroid treatments are given as a capsule or a drink instead. The delivery is not painful. Treatment is repeated in cycles several weeks apart, with blood tests between cycles and a response scan at set points. Here is the usual sequence.
1
Case review
Your reports, prior treatment and current scans are reviewed by the treating team before theranostics is considered at all.
2
Targeting scan
A tracer dose is given and a scan checks whether your cancer cells actually carry the target. This scan is the eligibility test, not a formality.
3
Fitness checks
Blood tests assess kidney function and bone marrow reserve, because the treatment is cleared through the body and can affect blood counts.
4
Treatment day
The dose is given by drip or injection over roughly twenty to sixty minutes, or as a capsule or drink for thyroid treatment. Fluids and anti-sickness support are given as your team advises.
5
Radiation-safety period
Depending on the agent, you are observed for some hours or stay in a shielded room. You go home with written precautions on contact, bathroom use and laundry for a defined number of days.
6
Next cycles and review
Cycles are repeated at planned intervals. A scan and blood tests at set points show how the disease is responding, and the plan is adjusted from there.
The practical parts of the safety period — the room, the rules, the family arrangements — are covered in detail in the isolation room stay during radioisotope therapy and in the household rules for living with someone after radioisotope therapy.
Access in India
Is theranostics available in India, and what does it cost?
Yes, at a limited number of licensed nuclear medicine departments — not at every cancer hospital. Handling and storing these agents needs a specific licence and shielded facilities under AERB radiation-safety requirements. Availability across Indian cities is widening, but it is still concentrated in larger centres, including Hyderabad.
Cost is not a single number. It depends on the agent used, the number of cycles planned and the scans that go with each cycle. Any figure you are quoted is indicative, as of August 2026, and a written estimate is issued before treatment starts. Insurance cover varies by policy and by agent, and pre-authorisation is worth checking before the first cycle rather than after it.
Your treatment is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout. CION does not own or operate the nuclear medicine facility. What CION does is get the right scan ordered, get the case reviewed by the right specialists, and stay with the family through the cycles — including for relatives coordinating from another city or another country. To start that conversation, call 1800 202 8726.
A framework, not a recommendation
Who is theranostics suitable for, and who is it not for?
Theranostics is considered when a targeting scan is positive and the rest of your health can tolerate it. It is most often discussed in advanced or recurrent disease, after standard options have been used or ruled out. It is not a general alternative to first-line treatment, and it is not offered on hope alone.
Usually considered when
- The targeting scan clearly shows the cancer cells carry the target.
- Disease is present in more than one site, so a single beam field would not cover it.
- Kidney function and blood counts are within the range the treatment needs.
- You are well enough to travel for cycles and follow the safety rules at home.
- A specialist team has reviewed the case and agrees it is appropriate.
Usually not the right fit when
- The targeting scan is negative, whatever the cancer type is called.
- Kidney function or bone marrow reserve is too low to tolerate the agent.
- A standard treatment with clearer evidence for your situation has not been tried yet.
- You are pregnant or breastfeeding, in which case the plan has to change.
- The urgent problem is a symptom that needs faster relief than a cycle-based plan can give.
Be careful with what you read online. Theranostics is a real and growing option, and it aims to control disease in patients who fit the criteria. It is not a fix for every cancer, and no honest team will promise you an outcome before your targeting scan is done. If someone quotes you a number over the phone, ask which guideline body it comes from.
From patients and families
Families Who Were Guided Through Specialised Treatment
Experiences from patients and from relatives coordinating care with CION, in Hyderabad and from abroad.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Theranostics — Your Questions Answered
What is theranostics in simple terms?
Theranostics pairs a scan with a matching treatment. A small dose of a radioactive tracer is given first, and a scan shows whether your cancer cells carry the target it looks for. If they do, the same targeting molecule is given again with a stronger radioactive particle attached, so the treatment lands on the cells the scan already identified. It is often described as: see what you treat, treat what you see.
How does theranostics differ from external radiation therapy?
External beam radiation is aimed at a mapped area from a machine outside your body. Theranostics is given as a medicine, usually into a vein, and it travels in the bloodstream to attach to cancer cells wherever they sit. External radiation suits disease in one region. Theranostics is generally considered when disease is in several places and the cells carry the right target. Your treating team decides which approach fits your situation.
Which cancers can be treated with theranostics?
Thyroid cancer is the oldest example, treated with radioactive iodine for decades. Neuroendocrine tumours are treated with a receptor-targeting radioisotope. Some advanced prostate cancers are treated with an agent that binds a protein carried on prostate cancer cells. Certain liver tumours are treated with tiny radioactive beads placed through the artery feeding the tumour. Bone-seeking agents are also used to control pain from cancer that has spread to bone. Eligibility always depends on what the targeting scan shows.
How is theranostics given, and does it hurt?
Most theranostic treatments are given as a slow injection or drip into a vein. Some thyroid treatments are given as a capsule or a drink instead. The delivery itself is not painful, though the drip can take twenty to sixty minutes. Treatment is usually repeated in cycles several weeks apart. Between cycles you have blood tests, and at set points a scan to see how the disease is responding.
Am I radioactive to my family after theranostic treatment?
For a short period, yes, to a limited degree. You carry the radioactive medicine until it decays and clears from your body. The nuclear medicine team gives you written precautions before you go home. These usually cover distance and time near young children and pregnant women, sleeping arrangements, bathroom use and laundry, for a defined number of days. The exact rules depend on the agent used and are set by the treating centre under AERB radiation-safety requirements.
Is theranostics available in India, and what does it cost?
Theranostic treatment is delivered at licensed nuclear medicine departments, not at every cancer hospital, and access across India is widening. Cost depends on the agent used, the number of cycles and the scans involved, so any figure is indicative, as of August 2026, and a written estimate is given before treatment starts. Your treatment is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout.